| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Henderson Jeffrey William is a Director at HALOZYME THERAPEUTICS, INC. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 13 sells.
Estimated insider holdings value: $6.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 4,497 | $60.37 | $271,467.09 | -7.3% | -4.7% | - | |
| Apr 1, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 503 | $64.05 | $32,217.15 | -1.5% | -15.9% | +5.7% | |
| Mar 3, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 5,000 | $58.69 | $293,458.31 | -6.6% | -4.0% | +19.7% | |
| Feb 10, 2025 | BDX Becton Dickinson & Co | Director | Buy | 1,500 | $233.62 | $350,430.00 | +23.0% | -23.3% | -2.8% | |
| Feb 3, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 5,000 | $56.30 | $281,516.80 | -5.8% | +7.7% | +35.9% | |
| Jan 6, 2025 | HALO Halozyme Therapeutics, Inc. | Director | Sell | 10,000 | $50.01 | $500,060.00 | -18.7% | +17.5% | +44.8% | |
| Sep 1, 2023 | KYNB Fibrogen Inc | Director | Sell | 2,000 | $1.03 | $2,060.00 | -6.5% | -47.9% | -65.5% | |
| Aug 4, 2023 | KYNB Fibrogen Inc | Director | Sell | 2,000 | $1.91 | $3,820.00 | -6.1% | -70.3% | -77.6% | |
| Jul 11, 2023 | KYNB Fibrogen Inc | Director | Sell | 2,000 | $2.69 | $5,380.00 | -5.7% | -73.6% | -66.9% | |
| Jun 8, 2023 | KYNB Fibrogen Inc | Director | Sell | 7,000 | $17.46 | $122,185.08 | -8.6% | -94.6% | -93.8% |